KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?

BACKGROUND: Glioblastomas (GBM) are typically comprised of morphologically diverse cells. Despite current advances in therapy, including surgical resection followed by radiation and chemotherapy, the prognosis for patients with GBM remains poor. Unfortunately, most patients die within 2 years of dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Valensin, Silvia, Ghiron, Chiara, Lamanna, Claudia, Kremer, Andreas, Rossi, Marco, Ferruzzi, Pietro, Nievo, Marco, Bakker, Annette
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711111/
https://www.ncbi.nlm.nih.gov/pubmed/19545421
http://dx.doi.org/10.1186/1471-2407-9-196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2711111/
https://www.ncbi.nlm.nih.gov/pubmed/19545421
http://dx.doi.org/10.1186/1471-2407-9-196

Ejemplares similares